When will Heparin Sodium Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Heparin Sodium Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Heparin Sodium Injection

Brand names: Heparin Sodium, Heparin Sodium In Sodium Chloride

Category: Hematology

Unavailable 1Limited 2Available 5

FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Nov 14, 2017 (in shortage 8 years 10 months) · 4 manufacturers, 8 listed presentations

As of Sep 22, 2026, the FDA lists Heparin Sodium Injection as currently in shortage. Of 8 manufacturer presentations, 1 Unavailable, 2 Limited, 5 Available.

Ask your pharmacist: which of the 4 manufacturers below can they order right now, and whether a different strength or form of Heparin Sodium Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) NDC 63323-519-77	Fresenius Kabi USA, LLC	Unavailable	Next release September 2026. Check wholesalers for inventory.
Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) NDC 0264-9872-00	B. Braun Medical Inc.	Limited	Estimated recovery: late Q4 2026; Manufacturing delays
Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) NDC 0264-9872-10	B. Braun Medical Inc.	Limited	Estimated recovery: late Q4 2026; Manufacturing delays
Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) NDC 0338-0433-04	Baxter Healthcare	Available	-
Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) NDC 0338-0431-03	Baxter Healthcare	Available	-
Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) NDC 63323-519-10	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20) NDC 0409-1005-20	Hospira, Inc., a Pfizer Company	Available	-
Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12) NDC 0409-2222-12	Hospira, Inc., a Pfizer Company	Available	-

Related medications in shortage

Other Hematology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Heparin Sodium Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Heparin Sodium Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Heparin Sodium Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/heparin-sodium-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).